Prognostic value of tumor markers ProGRP, NSE and CYFRA 21-1 in patients with small cell lung cancer and chemotherapy-induced remission

Association of CEA, NSE, CYFRA 21-1, SCC-Ag, and ProGRP with Clinicopathological Characteristics and Chemotherapeutic Outcomes of Lung Cancer

(2022) Huijuan Bi et al.   Labmedicine

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Small Cell Lung Cancer: Advances in Diagnosis and Management

(2020) Ayushi F. Chauhan et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Targeted Therapies and Biomarkers in Small Cell Lung Cancer

(2020) Hirokazu Taniguchi et al.   Frontiers in Oncology

Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer

(2018) Elif Tugce Korkmaz et al.   CLINICAL BIOCHEMISTRY

The prognostic value of the serum neuron specific enolase and lactate dehydrogenase in small cell lung cancer patients receiving first-line platinum-based chemotherapy

(2017) Xiaofan Liu et al.   MEDICINE

Progress and prospects of early detection in lung cancer

(2017) Sean Blandin Knight et al.   Open Biology

Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer

(2016) Rafael Molina et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

New ARCHITECT plasma pro-gastrin-releasing peptide assay for diagnosing and monitoring small-cell lung cancer

(2016) Benjamin Nisman et al.   BRITISH JOURNAL OF CANCER

Correlations between serial pro-gastrin-releasing peptide and neuron-specific enolase levels, and the radiological response to treatment and survival of patients with small-cell lung cancer

(2012) Akira Ono et al.   LUNG CANCER

Carcinoembryonic antigen (CEA) as tumor marker in lung cancer

(2011) M. Grunnet et al.   LUNG CANCER

Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in Monitoring First-Line Chemotherapy of Small Cell Lung Cancer

(2008) S. Holdenrieder et al.   CLINICAL CANCER RESEARCH

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER